Aureobasidium.org

patent 2023

Bio-healing agent-Hong Kong (Hong Kong License No. HK1136492)

Iwai A., Uchiyama H. · Hong Kong Intellectual Property Department
Research Archive
TL;DR — Key Findings
  • Hong Kong license protects AP β-glucan bio-healing agent applications.
  • Asia-Pacific IP coverage strengthens AP-glucan commercial position in key markets.
  • Multi-jurisdictional patent strategy demonstrates serious commercial investment in AP-glucan products.

Abstract

Bio-healing agent-Hong Kong (Hong Kong License No.HK1136492)

Patent Details

Country of RegistrationHong Kong

Patent No.No.HK1136492Registration DateNovember 29, 2013

Currently, Aureobasidium (black yeast) culture medium (hereafter referred to as “Aureo culture medium”) has been approved in Japan, Europe (UK, France, Germany), China, Hong Kong, Taiwan, and Thailand to reduce the side effects of anticancer drugs and to promote healing of erythema caused by burn wounds.

Summary

Summary

Patent Overview

Hong Kong License No. HK1136492 protects Aureobasidium pullulans-derived β-glucan as a bio-healing agent in Hong Kong. This registered license covers the use of N-163 strain β-glucan formulations for biological healing enhancement and immune support.

Significance

This Hong Kong intellectual property registration extends the bio-healing agent portfolio into the Hong Kong market, complementing the China (ZL200780040329.9), Taiwan (I364284), and other regional patents in the same family.

Citation

Iwai A., Uchiyama H.. Bio-healing agent-Hong Kong (Hong Kong License No. HK1136492). Hong Kong Intellectual Property Department. 2023.

Study Details
Study Type
patent
Published
2023
Journal
Hong Kong Intellectual Property Department
Authors
Iwai A., Uchiyama H.
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.